Alevacure is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. We are a research and development (R&D) driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled us to reach a range of target markets across over 3 countries, with a strong presence in India, Dubai and west Asia.

Our strong position in a number of therapeutic areas such as gynaecology, cardiovascular, blood-related, pain and analgesics and oncology/anti-neoplastics has been driven by our differentiated product portfolio and first to market product launches.

With its unwavering commitment to science, technology, and innovation, Alevacure is dedicated to addressing unmet medical needs and enhancing health outcomes by improving healthcare accessibility for patients worldwide.

Our advanced manufacturing and R&D capabilities drive high-quality, affordable healthcare through complex generics, biosimilars, and novel therapies, expanding our global impact and partnerships.